Goldman Sachs’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-131,060
Closed -$15.5M 5831
2021
Q1
$15.5M Buy
131,060
+26,509
+25% +$3.14M ﹤0.01% 1866
2020
Q4
$12.3M Buy
104,551
+65,254
+166% +$7.71M ﹤0.01% 1905
2020
Q3
$4.37M Sell
39,297
-28,648
-42% -$3.18M ﹤0.01% 2471
2020
Q2
$6.94M Buy
67,945
+37,390
+122% +$3.82M ﹤0.01% 2150
2020
Q1
$3.3M Sell
30,555
-88,761
-74% -$9.58M ﹤0.01% 2492
2019
Q4
$13.9M Buy
119,316
+72,376
+154% +$8.42M ﹤0.01% 1852
2019
Q3
$5.37M Sell
46,940
-6,682
-12% -$765K ﹤0.01% 2279
2019
Q2
$5.11M Sell
53,622
-80,330
-60% -$7.66M ﹤0.01% 2284
2019
Q1
$12.2M Buy
133,952
+37,949
+40% +$3.46M ﹤0.01% 1898
2018
Q4
$7.29M Buy
96,003
+16,027
+20% +$1.22M ﹤0.01% 2094
2018
Q3
$6.4M Sell
79,976
-32,659
-29% -$2.61M ﹤0.01% 2291
2018
Q2
$11.2M Sell
112,635
-512,521
-82% -$50.9M ﹤0.01% 1949
2018
Q1
$50.6M Buy
625,156
+27,757
+5% +$2.25M 0.01% 1055
2017
Q4
$47.1M Buy
597,399
+534,824
+855% +$42.1M 0.01% 1114
2017
Q3
$5.77M Buy
62,575
+1,171
+2% +$108K ﹤0.01% 2262
2017
Q2
$6.95M Buy
61,404
+2,845
+5% +$322K ﹤0.01% 2109
2017
Q1
$5.86M Buy
58,559
+5,091
+10% +$510K ﹤0.01% 2116
2016
Q4
$5.75M Sell
53,468
-86,598
-62% -$9.31M ﹤0.01% 2104
2016
Q3
$17.4M Buy
140,066
+102,804
+276% +$12.8M 0.01% 1547
2016
Q2
$3.96M Buy
37,262
+14,722
+65% +$1.57M ﹤0.01% 2257
2016
Q1
$2.58M Buy
22,540
+10,935
+94% +$1.25M ﹤0.01% 2388
2015
Q4
$1.65M Buy
+11,605
New +$1.65M ﹤0.01% 2617
2015
Q3
Sell
-6,035
Closed -$695K 4792
2015
Q2
$695K Sell
6,035
-9
-0.1% -$1.04K ﹤0.01% 3138
2015
Q1
$577K Buy
+6,044
New +$577K ﹤0.01% 3222